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Redox proteins of hydroxylating 
bacterial dioxygenases establish a 
regulatory cascade that prevents 
gratuitous induction of tetralin 
biodegradation genes
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Bacterial dioxygenase systems are multicomponent enzymes that catalyze the initial degradation of 
many environmentally hazardous compounds. In Sphingopyxis granuli strain TFA tetralin dioxygenase 
hydroxylates tetralin, an organic contaminant. It consists of a ferredoxin reductase (ThnA4), a 
ferredoxin (ThnA3) and a oxygenase (ThnA1/ThnA2), forming a NAD(P)H–ThnA4–ThnA3–ThnA1/ThnA2 
electron transport chain. ThnA3 has also a regulatory function since it prevents expression of tetralin 
degradation genes (thn) in the presence of non-metabolizable substrates of the catabolic pathway. This 
role is of physiological relevance since avoids gratuitous and wasteful production of catabolic enzymes. 
Our hypothesis for thn regulation implies that ThnA3 exerts its action by diverting electrons towards 
the regulator ThnY, an iron-sulfur flavoprotein that together with the transcriptional activator ThnR is 
necessary for thn gene expression. Here we analyze electron transfer among ThnA4, ThnA3 and ThnY by 
using stopped-flow spectrophotometry and determination of midpoint reduction potentials. Our results 
indicate that when accumulated in its reduced form ThnA3 is able to fully reduce ThnY. In addition, 
we have reproduced in vitro the regulatory circuit in the proposed physiological direction, NAD(P)H–
ThnA4–ThnA3–ThnY. ThnA3 represents an unprecedented way of communication between a catabolic 
pathway and its regulatory system to prevent gratuitous induction.
A wide range of aromatic compounds are major environmental pollutants, continuously discharged into the envi-
ronment through industrial and urban activities causing irreversible damage to the biosphere. Microbial catabolic 
potential allows using a variety of hazardous compounds as growth substrates. Aromatic catabolic pathways usu-
ally initiate biodegradation by incorporation of oxygen into the aromatics rings catalyzed by Rieske non-haem 
iron diooxygenases, a reaction requiring oxygen and reducing equivalents from NAD(P)H. These multicompo-
nent enzymes consist of a reductase, an oxygenase and, in some cases, an additional ferredoxin that mediates 
electron transfer between the former two components1. Further metabolism is achieved through hydroxylated 
aromatic intermediates. An efficient catabolic process imposes its catabolic genes being expressed at adequate 
levels only when the right substrates, those that the catabolic pathway can metabolize, are present, thus avoid-
ing energetically wasteful production of catabolic enzymes and potentially wasteful consumption of NAD(P)
H. Regulators of catabolic pathways are quite promiscuous, responding to distinct sets of structural analogues 
substrates and even to non-aromatic pollutants in some aromatic pathways2. This may result in a detrimental 
gratuitous induction of the pathway.
Sphingopyxis granuli strain TFA is able to grow with tetralin as a sole source of carbon and energy. Tetralin 
(1,2,3,4-tetrahydronaphthalene) is a bicyclic molecule composed of an aromatic and an alicyclic moiety, which is 
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found at low concentrations in different crude oils, and it is also industrially produced for its use as an organic sol-
vent. The degradation pathway has been characterized both at the biochemical and genetic levels3–7. As observed 
for other aromatic compounds, degradation of tetralin is initiated by dioxygenation of the aromatic ring, which 
is catalyzed by the tetralin dioxygenase enzymatic complex. This complex consist of a NAD(P)H-dependent 
ferredoxin reductase ThnA4 (NCBI protein accession number AAN26446), a ferredoxin ThnA3 (AAD52963), 
and a Rieske-type dioxygenase ThnA1/ThnA2 (AAN26443; AAN26444) that hydroxylates tetralin, forming the 
NAD(P)H-ThnA4–ThnA3–ThnA1/ThnA2 electron transport chain.
Expression of the tetralin biodegradation genes (thn) in S. granuli requires expression of the thnR and thnY 
regulatory genes. ThnR (AAU12855) is a LysR-type transcriptional activator that activates thn gene transcription 
in response to tetralin by binding to sites present at each of the four thn promoter regions7,8. ThnY (AAU12856) 
contains FAD and a plant-type [2Fe-2S] cluster and shows spectral features of the bacterial oxygenase-coupled 
NAD(P)H-dependent ferredoxin reductases. However, unlike ferredoxin reductases, purified ThnY is not 
reduced by NAD(P)H and instead has been recruited by the regulatory module. Addition of ThnYox to electropho-
retic mobility shift assays containing ThnR and a probe bearing the thn promoters indicated that ThnY directly 
promotes thn transcription activation by ThnR9. In addition, the ferredoxin ThnA3 adds an “extra” regulation by 
preventing expression of the thn genes when the inducer of the pathway is a poor substrate for the dioxygenase, 
avoiding gratuitous induction of the pathway. Thus, mutant strains lacking ThnA3 activate transcription of the 
catabolic pathway to high levels in response to compounds other than tetralin. On the other hand mutants lacking 
either the α (ThnA1) or β (ThnA2) subunits of the dioxygenase showed very low levels of thn expression even 
in the presence of tetralin. Based on these data, it has been proposed that ThnA3 exerts its regulatory function 
based on a redox sensory mechanism. Thus, under conditions in which the catabolic pathway cannot efficiently 
metabolize the inducer molecule (deficient electron flux to the dioxygenase), ThnA3 accumulates in its reduced 
form and prevents induction of tetralin gene expression10,11. We have found that some ThnY variants with amino 
acid substitutions in the cofactor binding site completely loose the discrimination capacity of the thn system11. 
These results suggest a unique regulatory model whereby ThnA3 signals are transmitted to the regulatory system 
via modification of the redox state of ThnY, forming a new regulatory NAD(P)H–ThnA4–ThnA3–ThnY electron 
transport chain.
By using stopped-flow spectrophotometry methods and determining midpoint reduction potentials of the 
implicated proteins, we demonstrate in this paper that the ferredoxin ThnA3 is the electron partner of ThnY. We 
have further analyzed the electron transfer processes between the NADP(H)-ThnA4ox, ThnA4red-ThnA3ox and 
ThnA3red-ThnYox couples, and reconstituted the electron transfer chain in the physiological direction proposed, 
ThnA4–ThnA3–ThnY. To our knowledge, this is the only case known where catabolic enzymes commonly asso-
ciated with the electron transport chain of dioxygenase systems are coupled to the regulatory proteins to adjust 
gene expression in response to the catabolic flux in the cell.
Results
Electron transfer from ferredoxin ThnA3red to ThnYox. Previous in vivo studies using mutated ThnY 
lead to the proposal of a model in which the interaction of ThnA3red with ThnY negatively modulates ThnY 
activity, through the reduction of ThnY and its subsequent inactivation11. The in vitro demonstration of the func-
tionality of the ThnA3-ThnY electron transfer process would strongly support the model for modulation of the 
regulatory system.
To investigate these facts, the hexahistidine-tagged versions of each of these proteins were purified by using 
metal chelate affinity and size exclusion chromatography. The His6-ThnY holoenzyme, containing FAD and a 
plant-type [2Fe-2S] cluster, was purified as previously reported9. ThnA3-His6 was here purified for the first time 
as a protein with an apparent molecular mass of 14 kDa, calculated from its mobility in SDS-PAGE, which agrees 
with the calculated from its coding sequence. The ThnA3 sequence bears the highly conserved metal-binding 
motif, CXHX15–17CX2H, containing the two cysteines and two histidines that co-ordinate the Rieske-type [2Fe-2S] 
cluster. Solutions of purified ThnA3ox were brown-coloured and have the typical absorption spectrum of a 
Rieske-type [2Fe-2S] cluster with maxima at 280, 320, and 461 nm, and a shoulder at 580 nm, and became fully 
reduced by dithionite (Supplementary Fig. S1a). Hence, ThnA3 displays similar spectral properties to those 
of the related ferredoxins from benzene, toluene, biphenyl, carbazole and napthalene dioxygenase systems12. 
Nevertheless, cluster incorporation in recombinant ThnA3 was incomplete, with an average of 35% of [2Fe-2S] 
incorporation, an observation commonly associated with over-expressed iron-sulfur proteins13. Herein this per-
centage was considered to calculate the amount of holo-ThnA3 in our kinetic and potentiometric assays. The 
electron transfer process from ThnA3red to ThnYox was analyzed by using stopped-flow spectroscopy, a method 
that can provide information on specific steps in the electron transfer reaction sequence and, therefore, will only 
imply ThnA3 in its holoprotein form when observing electron transfer. To do that we mixed a ~4-fold excess 
of an in vitro photoreduced solution of ThnA3 with ThnYox, and evolution of the process was followed over the 
visible range observing a general decrease in the absorbance. As shown in Fig. 1a, the excess of ThnA3red was able 
to fully reduce ThnYox under anaerobic conditions without detection of any traces of a semiquinone intermediate 
state. Different profiles for absorption evolution at 450 nm and 531 nm (inset Fig. 1a) as well as global analysis of 
the spectral evolution along the process were consistent with a two-step model, A → B → C, where three spectro-
scopic species can be distinguished (Fig. 1b). The initial species, A, practically results in the spectrum of ThnYox. 
Conversion of A into B occurs with an observed rate constant, kA→B, of 17.6 ± 1.5 min−1 under conditions of 
Fig. 1, with an absorbance decrease at the flavin band-I (around 450 nm) consistent with the two-electron reduc-
tion of the FAD cofactor of ThnY. In agreement, the spectrum of species B is consistent with the [2Fe-2S] cluster 
of ThnY remaining in the oxidized state. Spectroscopic changes for the final transformation of species B into C 
agree with the subsequent reduction of this [2Fe-2S] cluster (kB→C = 4.6 ± 0.6 min−1). Thus, spectrum for species 
C is consistent with a fully reduced ThnY.
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These results evidence that ThnA3 and ThnY are able to interact in solution and that ThnA3red is able to 
directly transfer electrons to the regulatory protein ThnY. Moreover, our results indicate that this electron transfer 
follows an ordered mechanism, with FAD reduction of ThnY occurring first and being its iron sulfur-center the 
one reduced in the final step.
Reduction of ferredoxin reductase ThnA4ox by NAD(P)H. Ferredoxin reductases of the dioxygen-
ases systems are known to supply reducing equivalents from NAD(P)H either directly to the terminal diox-
ygenase (Class I, two-component dioxygenase systems) or via an intermediary ferredoxin (Class II and III, 
three-component systems)1. In vivo, in the tetralin dioxygenase enzyme complex, (ThnA4–ThnA3–ThnA1/
ThnA2), the ferredoxin reductase ThnA4 is postulated to transfer reducing equivalents from NAD(P)H to 
ferredoxin ThnA36. ThnA4 encodes a 339-amino acid polypeptide, 45% identical to the ferredoxin reductases 
of the class III dioxygenase systems. These reductases share an N-terminal domain that contains a conserved 
Cys-X4-Cys-X2-Cys- X29/30-Cys motif that binds a plant-type [2Fe-2S] cluster, while the central and C-terminal 
domains contain the conserved motifs for flavin and NAD(P)H binding, respectively9. To in vitro analyze the 
reduction of ThnA3 under conditions closer to the physiological ones, (NAD(P)H–ThnA4–ThnA3), we also pro-
duced for first time recombinant ThnA4-His6 purified at homogeneity and studied its ability to accept electrons 
from pyridine nucleotides. Although ThnA4-His6 loses significant amounts of its flavin FAD cofactor during 
purification, upon FAD reconstitution its UV-visible air-oxidized spectrum revealed the typical absorption max-
ima at 276, 370, 421, and 461 nm, and a shoulder at about 550 nm, the later disappearing upon reduction by 
dithionite (Supplementary Fig. S1b). Thus, reconstituted ThnA4-His6 contains the expected FAD and [2Fe-2S] 
redox centers, showing similar spectral features to the reductases from the benzoate 1,2-dioxygenase14, naptha-
lene dioxygenase15, 2-halobenzoate 1,2-dioxygenase16, and carbazole dioxygenase17 systems.
Reduction of ThnA4ox by NAD(P)H was also analyzed by fast-kinetic stopped-flow. Spectral evolution after 
mixing ThnA4ox with NADH under anaerobic conditions clearly showed reduction of the enzyme (Fig. 2a). 
Similar results were also obtained under aerobic conditions and when NADPH was used as electron donor (not 
shown), indicating that ThnA4ox can catalyze the oxidation of both coenzymes. Decrease in the absorbance at 
461 nm upon reaction was concomitant with the appearance of a broad small long-wavelength band centered 
at 625 nm consistent with the appearance of a flavin-nicotinamide charge transfer complex along the reaction 
that finally bleaches (Fig. 2a,b). Global analysis of the spectral evolution shown in Fig. 2a was consistent with a 
two-step model (Fig. 2b,c). The first step, A → B, accounted for bleaching of the flavin band with the concomi-
tant appearance of the long-wavelength charge transfer band. Transformation of B into C occurred with a rate 
Figure 1. Anaerobic reduction of ThnYox by ThnA3red. (a) Spectral evolution of the reaction of ThnYox 
(~8 μM) with photoreduced ThnA3red (~24 μM holoenzyme) as measured by stopped-flow spectrophotometry. 
Spectra recorded at 0.00128, 0.04736, 0.4109, 0.8614, 1.778, 3.488, 5.382, 8.25, 11.74, 17.8, and 54.38 s after 
mixing are shown. Direction of the spectral evolution is indicated by arrows. The inset shows the absorbance 
evolution at 451 nm (black line) and 531 nm (grey line) and their corresponding global fits to a two-steps 
model, A → B → C (bold black lines). (b) Spectroscopic properties of the intermediate pre-steady-state species. 
The inset shows the evolution of the obtained spectral species over the time. Species A, B and C are shown as 
continuous black thin, black bold and grey bold lines, respectively. Measurements carried out in potassium 
phosphate 50 mM, pH 7.4, NaCl 10 mM, glycerine 5%.
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constant ~7-fold slower than the initial process and accounted for the disappearance of the charge transfer com-
plex band (Fig. 2a–c). When we used large coenzyme concentrations, and after a relatively long lag phase, conver-
sion of C into a final D species was also observed, with spectral changes consistent with achieving full reduction 
of FAD and [2Fe-2S] clusters (not shown).
kA→B values showed a saturation profile on NADH concentration that allowed us to estimate a limiting hydride 
transfer rate constant from NADH to ThnA4ox, kredNADH, of 22.1 ± 2.3 min−1, while suggesting a KdNADH value 
lower than 0.4 μM. kA→B values for NADPH showed a concentration saturation dependence that allowed fitting 
of the data to the equation describing binding at a single site followed by the hydride transfer processes and 
determination of the NADPH:ThnA4ox dissociation constant (KdNADPH, 54 ± 13 μM) and the hydride transfer rate 
from NADPH to the FAD cofactor (kredNADPH = 30.5 ± 2.1 min−1) (Fig. 2d). These parameters indicate that despite 
limiting rate constants for hydride transfer to ThnA4ox are very similar for both coenzymes, the affinity of Thn4ox 
for NADH is considerably higher than that for NADPH. These data are consistent with a higher efficiency for the 
process with NADH, indicating it as the preferred physiological hydride donor to ThnA4ox. Similar results were 
obtained regardless using aerobic or anaerobic conditions and the reverse reaction was undetectable under our 
experimental conditions, with the only exception of a very slow reverse reaction (kreox = 0.16 min−1) for the pro-
cess with NADPH under aerobic conditions. These results agree with observations in other related systems where 
the reductases, such as the ones of phthalate, toluene and benzene dioxygenases, are very specific for NADH18–20, 
while others less specific showed also preference for NADH over NADPH15.
Reduction of ferredoxin ThnA3ox by ferredoxin reductase ThnA4. Once demonstrated that ThnA4 
is functionally reduced by NAD(P)H, we also analyzed its ability to transfer electrons from NADH to ThnA3ox. 
With this aim we followed the spectral evolution upon mixing under anaerobic conditions an excess of ThnA3ox 
with ThnA4red, which was formed by previous incubation of ThnA4ox with NADH (Fig. 3). The spectral shape 
of ThnA3ox rapidly changed after mixing with ThnA4red and its absorption peaks were displaced to 435 and 
522 nm (Fig. 3a). These absorbance maxima are characteristic of reduced Rieske-type ferredoxins of aromatic 
Figure 2. Reduction of ThnA4ox by NADH. (a) Spectral evolution of ThnA4 (~2.5 μM) along reaction with 
NADH (~2.5 μM) as measured by stopped-flow spectroscopy under anaerobic conditions. The thick dashed 
black line corresponds to the spectrum of ThnA4ox before mixing. Spectra recorded at 0.08064, 0.1626, 0.3264, 
0.8179, 1.309, 2.456, 3.931, 5.242, 7.29, 10.07, and 30.23 s after mixing are shown. Directions of the spectral 
evolutions are indicated by arrows. (b) Evolution of the absorbance at 458 nm (line) and 625 nm (dotted line) 
and their corresponding global fits (bold lines) to a two-steps model, A → B → C. (c) Spectroscopic properties 
of the intermediate pre-steady-state species. The inset shows the evolution of the obtained spectral species over 
the time. Species A, B and C are shown as continuous black thin, black bold and grey bold lines, respectively. (d) 
Observed kA→B values as a function of NADH (filled squares) and NADPH (open circles) concentrations. Lines 
represent data fit to Eq. 1. Experimental conditions as in Fig. 1.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:23848 | DOI: 10.1038/srep23848
systems such as BphA3 of the biphenyl dioxygenase complex from Pseudomonas sp. KKS10221, the ferredoxinNAP 
component of naphthalene dioxygenase from Pseudomonas17 and the CarAc component of the carbazole 
1,9α -dioxygenase15. The overall process fit to a three-step model (Fig. 3a, inset, and 3b). Species A resembled 
the ThnA3ox spectrum. Transition of A into B was related with a slight increment in the absorption of the 460 
band and a decrease in the 600 nm band, changes consistent with the production of the interaction between both 
proteins. Transition of B into C related with absorption decrease in the whole wavelength range consistent with 
reduction of ThnA3ox by the NADH reduced ThnA4. Transformation of species C into D is a considerably slower 
process that accounts for a very small change in amplitude, probably related with final consumption of the excess 
of reduced coenzyme and the achievement of the steady-state equilibrium.
Altogether these results indicate that ThnA4 functions as a conventional NAD(P)H-dependent oxidoreduc-
tase of the dioxygenase systems, accepting a hydride from NAD(P)H by its flavin cofactor and transferring the 
two obtained electrons one at a time through its [2Fe-2S] cluster to the one-electron acceptor ThnA3 ferredoxin.
Reconstitution of the regulatory electron transfer NADH–ThnA4–ThnA3–ThnY chain. Since 
ThnA3red is able to reduce ThnYox when its iron cluster is photoreduced (Fig. 1) and NADH reduced ThnA4 
(Fig. 2) is able to reduce ThnA3ox (Fig. 3), we finally attempted to in vitro reconstitute the regulatory 
electron-transport chain in the proposed physiological direction by testing the reduction of the regulatory ThnYox 
by NADH via ThnA4 and ThnA3. Results for the anaerobic reconstitution of this system are shown in Fig. 4. 
Anaerobic stopped-flow measurements were carried out after mixing ThnA4red, reduced by preincubation with 
NADH, with a mixture containing ThnA3ox and ThnYox. Spectral changes clearly indicated that ThnYox became 
completely reduced along the reaction time-course. Global analysis of the spectral evolution fit to a four-step 
model, A → B → C → D → E (Fig. 4a, inset and b). The initial intermediate species, A, is consistent with a mixture 
that mainly contains ThnA3ox, ThnYox and ThnA4red. Conversion of A into B shows a slight absorbance increase 
that can be related with complex formation among the proteins present in solution. Conversion of B into C is 
consistent with reduction of the [2Fe-2S] center of ThnA3 with a conversion rate constant, kB→C = 110 min−1, 
very similar to that above obtained for the reduction of ThnA3ox by ThnA4red in the absence of ThnY (Fig. 3). 
Conversion of C into D indicates reduction of the FAD of ThnY, with an observed rate constant, kC→D = 15 min−1, 
in the range described above by the first step in the analysis of the reduction of ThnYox by photoreduced ThnA3 
(Fig. 1). Evolution to species E indicates final reduction of the three proteins with an observed rate constant of 
Figure 3. Anaerobic reduction of ThnA3ox by ThnA4red. (a) Spectral evolution of the reaction of ThnA3ox 
(~14 μM holoenzyme) with ThnA4red (~5 μM, previously reduced with 50 μM NADH) as measured by stopped-
flow spectroscopy under anaerobic conditions. Spectra recorded at 0.00384 (dashed line), 0.03968, 0.2138, 
0.5082, 22.14, and 220.8 s after mixing are shown. The inset shows the evolution of the absorbance at 452 nm 
(grey bold line) and 462 nm (thin black line), as well as their corresponding global fits (bold lines) to a three-
steps model, A → B → C → D. (b) Spectroscopic properties of the intermediate pre-steady-state species. The 
inset shows the evolution of the obtained spectral species over the time. Species A, B, C and D are shown as 
continuous black thin, black bold, grey bold and grey dashed lines, respectively. Experimental conditions as in 
Fig. 1.
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2.4 min−1, again comparable with the values for the second steps of both the reduction of ThnYox by ThnA3red 
(Fig. 1) and of ThnA3ox by ThnA4red (Fig. 3). Similar results were obtained under aerobic conditions, although in 
the presence of air the spectrum of ThnYox resulted regenerated at the end of the reaction. Control experiments in 
which ThnYox reduction was monitored in the absence of ThnA3, both under the same experimental conditions 
as well as in the presence of oxygen, showed that ThnA4red was unable to reduce ThnYox. These results confirm i) 
the requirement of ThnA3 for the efficient reduction of ThnYox, as well as ii) the fact that we have reproduced in 
vitro the regulatory electron transfer chain from NADH to ThnYox via ThnA4 and ThnA3, as it is proposed to 
occur in vivo.
Redox potentials values of ThnA4, ThnA3 and ThnY. Midpoint reduction potentials (Em), for ThnA3, 
ThnY and ThnA4, were determined by potentiometric titration and analysis of their visible spectra upon anaerobic 
photoreduction (Fig. 5). Spectral characteristics along photoreduction of ThnA3 were consistent with reduction of 
the [2Fe-2S] cluster in a process exchanging a single electron (Fig. 5a). Global fitting of data at several wavelengths 
to Eq. 2 allowed determination of a midpoint potential, EThnA3SFeox/red, of − 112 ± 5 mV (Fig. 5a inset). Spectra 
recorded upon photoreduction of ThnY showed the almost simultaneous reduction of its FAD (flavin band-I 
decrease at 454 nm) and [2Fe-2S] (absorption decrease at 530 nm) redox cofactors (Fig. 5b). Additionally, an 
absorption evolution at 380 nm consistent with the appearance of traces of anionic semiquinone along reduction 
was observed. Nevertheless, we observed that its maximal stabilization was too small to expect independent deter-
mination of the midpoint reduction potentials for the two individual oxido-reduction couples (Eox/sq and Esq/hq). 
The plot of different wavelengths relative absorptions versus the measured potentials was globally fit to Eq. 3, 
allowing determination of EThnYFADox/hq and EThnYSFeox/red with values of −131 ± 8 mV and −136 ± 8 mV, respec-
tively (Fig. 5b inset). Photoreduction of ThnA4 resulted in the extremely slow stabilization of the potential values 
after each reduction step, increasing the experimental time and the protein denaturation along the experiment. 
This enforced us to measure potentials and their corresponding absorption spectra at fixed times after each illu-
mination event, that prevented accurate determination of midpoint potentials. Therefore, this experiment only 
suggested that EThnA4FADox/hq and EThnA4SFeox/red values must be in the −200 mV to −150 mV ranges respectively.
Figure 4. Reconstitution of the complete electron transfer chain: anaerobic reduction of ThnYox by 
NADH throughout ThnA3ox and ThnA4ox. (a) Spectral evolution of the mixing ThnA4red (~2.5 μM of protein 
preincubated with 50 μM NADH, in syringe 1) with a mixture containing ThnA3ox (~25 μM holoenzyme) and 
ThnYox (~7.5 μM) (in syringe 2) in the stopped-flow equipment under anaerobic conditions. Spectra at 0.00384, 
0.03968, 0.754, 0.887, 4.317, 8.982, 18.68, 38.31, 103, and 197 s after mixing are shown. The inset shows the 
spectral evolution at 455 nm (black line) and 600 nm (grey line), as well as and the corresponding global fits 
(bold lines) to a four-steps model, A → B → C → D → E. (b) Spectroscopic properties of the intermediate pre-
steady-state species. The inset shows the evolution of the obtained spectral species over the time. Species A, B, 
C, D and E are shown as continuous black thin, black bold, grey bold, grey dashed and dotted lines, respectively. 
Experimental conditions as in Fig. 1.
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A schematic diagram with the midpoint reduction potentials and the inter and intra-molecular electron trans-
fer steps is shown in Fig. 6. The ThnY midpoint reduction potential is slightly more electronegative than that 
of ThnA3, thus indicating that electron transfer in the direction ThnA3 → ThnY is only possible when ThnA3 
accumulates in its reduced form (such condition will displace the actual reduction potential of ThnA3 to more 
negative values than the one determined as midpoint potential).
Discussion
A feature of the regulatory systems of many biodegradation pathways is that the range of inducer molecules 
to which they respond is not the same as the range of substrates that the catabolic pathway can transform, 
Figure 5. Potentiometric titrations of ThnA3 and ThnY. Spectral changes during photoreduction of (a) 
ThnA3 (∼ 20 μM) and (b) ThnY (∼ 5 μM). Buffers were supplied with 5-deazariboflavin, EDTA and the 
corresponding chemical mediators. Titrations were carried out at 15 °C in potassium phosphate 50 mM, pH 
7.4 for ThnA3 and in 0.1 M HEPES, pH 7.4 for ThnY. Arrows indicate direction of spectral changes. The insets 
show multiple wavelength variation of the relative absorptions plotted against the redox potential of the solution 
(mV/SHE) at; (a) 590 (■ ), 520 (●) and 462 (Δ) nm for ThnA3 and (b) 530 (■), 450 (○) and 380 (Δ) nm for ThnY. 
Continuous lines show simultaneous fits of the different wavelength data to Eq. 2 for ThnA3 and Eq. 3 for ThnY.
Figure 6. In vivo electron transfer pathway proposed for the reduction of ThnY by NAD(P)H via ThnA4-
ThnA3. Midpoint reduction potentials are indicated for each redox cofactor. Complete results for their 
determination are shown in Fig. 5. Inter and intramolecular electron transfers are represented by arrows.
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therefore resulting in a superfluous and energetically wasteful production of catabolic enzymes unable to use the 
non-metabolizable molecules. Some regulators recognize as effectors molecules those with structural analogy to 
the substrate or even quite dissimilar compounds. Representative examples are DmpR and XylR, σ 54-dependent 
regulators for catabolism of aromatics hydrocarbons such as (methyl)phenol and toluene/xylene respectively, 
which exhibit a very broad effector specificity2. Other catabolic pathways in order to prevent uncoordinated 
induction express the biodegradation genes not in response to the substrate but to some intermediate in the 
catabolism of the substrate2,22,23. However, this response implies high basal levels of expression to accumulate 
sufficient inducer intermediate to allow substantial degradation of the substrate. In addition, gratuitous induction 
is not fully prevented since some inducer intermediates may be produced through different peripheral routes that 
use different catabolic substrates.
The in vivo model for thn gene regulation presented in Fig. 7 proposes that ThnA3 reports to the regulatory 
ThnR-ThnY system whether a potential inducer molecule is also a good substrate of the catabolic pathway, based 
in a redox sensory mechanism10. In recent years, much progress has been made in understanding how Fe-S clus-
ters regulatory proteins reprogram the expression of genes in response to environmental stimuli. A challenging 
question is to relate both the in vitro reactions of Fe-S clusters with its physiological relevance24. Our model is 
quite unique, since ThnA3 is the only ferredoxin that takes part in oxidative hydroxylation of aromatic com-
pounds known to be involved in regulation of gene expression. Therefore, it is a crucial question to elucidate the 
mechanism by which ThnA3 exerts its function.
The expression phenotypes of the ThnY mutants have provided genetic evidences indicating that control of the 
ThnY redox state is essential for efficient regulation of thn genes, since some of the thnY mutations in the electron 
cofactor binding sites alter the range of molecules able to activate the catabolic pathway. In this way, thnY mutant 
strains behave as the mutants lacking ThnA3, expressing thn genes in the presence of not suitable molecules such 
as cis-decalin, cyclohexane, trans-decalin, or benzene11. These findings and the in vivo model imply that under 
certain circumstances, electrons from NAD(P)H that are accumulated in ThnA3 are redirected towards ThnY 
instead of the dioxygenase, (NAD(P)H–ThnA4–ThnA3–ThnY electron chain), thus resulting in ThnY inacti-
vation. To provide biochemical evidences of this regulatory electron transport chain, we have characterized the 
sequence for electron transport in this system. Our results clearly show that when the [2Fe-2S] cluster of ThnA3 
is photoreduced or reduced by its physiological NADP(H) electron donor (ThnA4), it is able to reduce both the 
flavin and the [2Fe-2S] cluster of ThnY, thus strongly supporting the proposed regulatory model for the regulation 
of thn.
According to this model, ThnA3 is predominantly in its oxidized form in the presence of tetralin (Fig. 7a), the 
real substrate of the catabolic pathway. Reduction of ThnY by ThnA3 is minimal under these conditions, since 
Figure 7. Model for the regulation of thn genes in response (a) to tetralin and (b) to non-metabolizable 
substrates. Blockage of electron transfer is represented by dotted crosses. The sizes of the circles indicate the 
relative abundance of that form of the protein according to the substrates supplied.
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electrons would be preferentially transferred to the dioxygenase, thus allowing ThnR and ThnYox to activate the 
thn promoters. In the absence of an efficient substrate that acts as an electron sink through the dioxygenation 
reaction (Fig. 7b), ThnA3 is accumulated in its reduced state. As a result, reduction of ThnYox by ThnA3red will 
take place, switching ThnY into an abundant reduced form, thus impairing thn gene transcription.
Analogous proteins to ThnA4 and ThnA3 have been reported to function in the multienzyme systems that 
dioxygenate the aromatic substrates to cis-dihydrodiols. ThnA4 has several properties in common with the 
three-component oxygenase systems that catalyze reduction of ferredoxin from NAD(P)H: similar molecular 
weight, two prosthetic groups in a single polypeptide, a loosely bound molecule of FAD, and preference toward 
NADH. In fact the expected range for midpoint potentials for ThnA4 (EThnA4FADox/hq and EThnA4SFeox/red) is in agree-
ment with its role as NAD(P)H ferredoxin reductase. For comparison, in the phthalate dioxygenase reductase, 
PDR, the Em for flavin is − 230 mV, and the one-electron potential of [2Fe-2S] is − 17418. Similarly ThnA3 shares 
common properties to the ferredoxin type protein of multicomponent dioxygenases enzymes, they are all one 
electron carriers, each has a Rieske-type [2Fe-2S], have similar molecular weights and they are rather specific 
for the dioxygenase system1. However, reduction potentials of the dioxygenase ferredoxins25 are approximately 
− 150 mV. The EThnA3ox/red (− 112 mV) is also comparable although clearly less negative than those found in ferre-
doxin Rieske counterparts. For comparison, the Em for Rieske-type ferredoxins of aromatics benzene and biphe-
nyl dioxygenases, or toluene 4-monooxygenase are − 155, − 157, and − 173 mV, respectively26–28. On the other 
hand, the EThnYox/red (− 131 and − 136 mV) are less negative too than those of other ferredoxin reductases coun-
terparts and slightly more negative than that of ThnA3 (Fig. 6). These values indicate that although when looking 
at midpoint reduction potentials electron transfer in the direction ThnA3 to ThnY is not favored, the situation 
can change when ThnA3 accumulates in the reduced form and its effective reduction potential becomes more 
negative. Moreover, these midpoint potentials fit well with the notion that ThnYox should not efficiently compete 
with the dioxygenase for the electrons coming from ThnA3 and, therefore, ThnY should only be reduced when 
ThnA3red is highly accumulated in vivo and the equilibrium for the redox reaction changes. Actually, non-favored 
electron transfer from ThnA3 to ThnY may probably be essential for an efficient gene regulation because other-
wise ThnY could always be reduced by ThnA3red, thus preventing transcription of thn genes under all conditions.
In conclusion, in vivo expression of the thn genes is prevented when reductive inactivation of ThnY occurs. 
This may happen (i) in the presence of an inducer molecule that is not a substrate of the dioxygenase and conse-
quently high levels of ThnA3red are accumulated10, (ii) in the thnA1 or thnA2 mutant strains, lacking of the dioxy-
genase subunits, in which all ThnA3red is fully available to interact with ThnY and thn expression is impaired even 
in the presence of tetralin10 and (iii) when the inducer is also a substrate but its concentration is very low. Thus, 
under these conditions, redox equilibria favor electron transfer in the direction NADH  → ThnA4FAD → ThnA4
[2Fe-2S] → ThnA3[2Fe-2S] → ThnYFAD → ThnY[2Fe-2S] that we have reproduced in vitro. This way, the redox regulation 
exerted through ThnA3 not only prevents gratuitous induction by a non-metabolizable molecule but also may 
finely adjust the level of transcription of thn genes to the availability of the substrate.
Methods
Plasmids and strains constructions. Plasmids, strains, and primers used in this work are listed in 
Supplementary Table S1.
Plasmid pMPO785 to overproduce His6-ThnY was performed by PCR amplification of thnY 
with primers NdeI-thnY2 (5′AAAAACATATGGAAATCACCCTCATCC3′) and thnY-BamHI 
(5′AAAAAGGATCCTTACGAAACAGAAAAATGGTAAGG3′) using pMPO750 as template. thnY was cloned 
into pET-14b, PCR product and vector were cleavage with NdeI+BamHI.
The ThnA3-His6-overproducing plasmid pMPO760 was constructed amplifying thnA3  by 
PCR with pr imers  NdeI-thnA3 (5 ′CACATATGGGACGTAAGGT TAG3 ′)  and thnA3-XhoI 
(5′GGCTCGAGATCAAGATCCGCGA3′), using pMPO751 as the template. The PCR product was cleaved with 
NdeI+XhoI and cloned into pET23a digested with the same enzymes.
Plasmid pMPO784, which contains thnA4-His6, was constructed by using primers NdeI-thnA4 
(5′GACATATGGGCAGCGCGCGCAT3′) and thnA4-XhoI (5′GCCTCGAGGACAAAGCTGTC3′). The final 
DNA fragment was digested with NdeI+ XhoI, and was introduced into pET23b digested with the same enzymes.
E. coli DH5α was used as a host in all cloning procedures40. All DNA manipulations were performed accord-
ing to standard procedures29. Plasmid DNA was transferred to competent cells of E. coli strains by heat shock 
transformation. When required, antibiotics were used at the following concentrations: ampicillin, 100 μg/ml, 
chloramphenicol, 15 μg/ml, and gentamicin, 10 μg/ml.
Purification of recombinant proteins. Expression and purification of His6-ThnY (containing an 
N-terminal His6 tag), ThnA3-His6 (C-terminal His6 tag) and ThnA4-His6 (C-terminal His6 tag) proteins were 
performed as previously described9 with the following modifications: cultures of E. coli NCM631 harboring 
the plasmid pIZ22741 and either pMPO784, (thnA4-His6), pMPO760, (thnA3-His6) or pMPO785 (His6-thnY), 
were grown in LB medium containing ampicillin and chloramphenicol overnight. They were used to inoculate 
1 liter of Terrific Broth medium29 supplemented with extra iron and sulfur sources (0.1 mg/ml ferric ammo-
nium citrate, 0.1 mg/ml ferric citrate, 0.1 mg/ml iron sulfate heptahydrate, 0.1 × ferrous sulfate/chelate solu-
tion, and 1 mM cysteine), and 4 mg/ml riboflavin for His6-ThnY and ThnA4-His6. Expression of thnA3-His6 or 
thnA4-His6 was induced by adding 0.5 or 0.05 mM of isopropyl β -D-thiogalactopyranoside respectively, for 15 h 
at 16 °C. For ThnA4-His6, it was necessary to add 2 mM FAD during the cell disruption by sonication to obtain a 
ferredoxin reductase with both, the iron sulfur-cluster and flavin, cofactors bound. Cell extracts were applied to 
an IMAC column (TALONTM resin (Clontech)) according to the manufacturer’s specifications and bound pro-
teins were eluted with an increasing imidazole gradient. Fractions exhibiting the expecting size and with color, 
indicative that some chromophores must be bound, were pooled, concentrated and applied to a Superdex 75 pg 
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column (10/60). Purified proteins were stored at − 80 °C in 50 mM Tris-HCl buffer, pH 7.4 containing 250 mM 
NaCl, and 10% glycerol. To measure His6-ThnY and ThnA4-His6 concentrations, the extinction coefficient of 
each protein (ε 454 nm = 21.8 M−1 cm−1) and (ε 461 nm = 19.5 M−1 cm−1) respectively, were calculated using the same 
procedure described for ThnY-His69. ThnA3-His6 concentration was determined by the Bradford method using 
bovine serum albumin as the standard. The application of different methods (including absorption spectroscopic 
methods and Fe quantification by inductively coupled plasma) in the attempt to determinate the protein extinc-
tion coefficient, indicated that [2Fe-2S] cluster incorporation was incomplete, with an average of 35% of incor-
poration. This prevented determination of the extinction coefficient. UV-Vis spectra were recorded either in a 
Shimadzu UVPC-1603 or in a Cary-100 spectrophotometer.
Stopped-flow pre-steady-state kinetic measurements. Transient electron transfer reactions among 
different couples of the Thn proteins, as well as from NAD(P)H to all of them were analyzed (reduction by 
NAD(P)H was only efficiently observed for ThnA4) by following the absorption spectral evolution in the flavin 
and iron sulfur regions (400–900 mm) using an Applied Photophysics SX17MV stopped-flow equipped with a 
photodiode array detector at 15 °C30. All samples were prepared in potassium phosphate 50 mM, pH 7.4, NaCl 
10 mM, glycerine 5%. Multiple wavelength absorption data were collected and processed using the X-Scan soft-
ware (Appl. Phot. Ltd). Time spectral deconvolution was performed by global analysis and numerical integra-
tion methods using Pro-Kineticist (Appl. Phot. Ltd.). The collected data were fitted either to single-step, A → B, 
two-steps, A → B → C, three-steps, A → B → C → D, or four-steps A → B → C → D → E models allowing esti-
mation of the observed conversion rate constants (kA→B, kB→C, kC→D). These observed rate constants describe the 
reaction under a particular set of conditions, being not limiting values, and are estimated with errors lower than 
± 10%31. However, values representing processes involving ThnA3 must be considered only from the qualitative 
point of view due to the low proportion of holoprotein exhibited by this protein. Model validity was assessed by 
lack of systematic deviations from residual plots at different wavelengths, inspection of calculated spectra and 
consistence among the number of significant singular values with the fit model. kA→B rate constants derived from 
experimental data for the reaction between NAD(P)H, (2.5–150 μM range), and ThnA4ox showed a dependence 






k k K NAD P H k NAD P
NAD P H K
( [ ( ) ]) [ ( ) ]





allowing to estimate limiting values at equilibrium for the dissociation (Kd) and the hydride transfer rate constants 
for the forward and reverse reactions (kred, kreox) as previously described32,33. In general, errors in the estimated 
values for Kd and kred were lower than ± 20% and ± 15%, respectively.
Determination of midpoint reduction potentials for ThnA4, ThnA3 and ThnY. Potentiometric 
titrations of ThnA4, ThnA3 and ThnY, were attempted at 15 °C by photoreduction under anaerobic conditions. 
Solutions contained 5 μM ThnA4 or ThnY, or 20 μM ThnA3, as well as 3 mM EDTA and 2 μM 5-deazariboflavin. 
Measurements were carried out in potassium phosphate 50 mM, pH 7.4, NaCl 10 mM, glycerine 5% for ThnA3 
and ThnA4, and in HEPES 0.1 M pH 7.4, guanidine chloride 0.1 M, DTT 1 mM, EDTA 0.1 mM, glycerine 17% 
for ThnY. As mediators we used benzylviologen (Em = − 359 mV) and indigo disulphonate (Em = − 125 mV) for 
ThnA3; indigo disulphonate, benzylviologen and 1,2-naphtoquinone (Em = +143 mV) for ThnY, and benzylviolo-
gen, indigo disulphonate and anthraquinone-2-sulphonate (Em = −225 mV) for ThnA4. Stepwise reduction of the 
proteins was achieved by photoreduction and potentials along reduction were determined using a calomel elec-
trode as reference (Em = − 251.1 mV at 15 °C) and a gold electrode as working one, as previously described34. The 
system was considered equilibrated when the potential of the solution (E), measured with a Fluke 177 true-RMS 
multimeter, remained stable for at least 10 min. UV-vis absorbance spectrum was then recorded. In the case of 
ThnA4, the extremely slow stabilization of the potential values after each reduction step as well as the subsequent 
denaturation of the protein upon reduction enforced us to measure potential values and their corresponding 
absorption spectra after 15 min of each illumination step. This was in detriment of the accuracy in determination 
of the midpoint potentials for this protein. Experiments were performed in duplicate.
Data were analyzed using the Origin Software (OriginLab) based on previously described methods35–39 
using Equation 2 for ThnA3 and Equation 3 for ThnY and ThnA4. These equations, derived by extension to the 
Nernst equation and the Beer–Lambert Law, respectively describe a one-electron redox process or the sum of a 
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where RelAbs corresponds to the ratio between the sample absorption, at a given wavelength and at a particular 
stage of the reduction, and the maximal observed for such wavelength; SFeox, SFered, FADox, and FADred corre-
spond to the relative contribution to the total RelAbs at each wavelength and stage of reduction of the oxidized 
and reduced forms of the [2Fe-2S] and FAD redox centers; E is the experimentally measured potential at each 
state of the reduction; and EmSFox/red and EmFADox/red correspond respectively to the one-electron midpoint potential 
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of the [2Fe-2S] cluster and the two-electron midpoint potential of the flavin cofactor. The complexity of the 
system, particularly for ThnY and ThnA4 (three-electron titration with probable overlap of midpoint potentials 
and the presence of several dyes) necessitated the use of a global fitting process. Thus RelAbs at several wave-
lengths were simultaneously plotted against the redox potential of the solution (mV/SHE) and fit to either Eq. 2 or 
Eq. 3. Errors in the determined Emox/red were estimated to be ± 8 mV for ThnA3 and ThnY, but values larger than 
± 30 mV are expected for ThnA4.
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